Back to TARS
BANK OF AMERICA CORP /DE/ → TARS
BANK OF AMERICA CORP /DE/ TARS Position History
Tarsus Pharmaceuticals, Inc. • Healthcare
Quarters held
22
Latest value
$1.1M
Q2 2026
Peak value
$65.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $10.2M |
| Q3 2025 | $16.2M |
| Q3 2025 | $595K |
| Q3 2025 | $59 |
| Q3 2025 | $3.9M |
| Q3 2025 | $994K |
| Q4 2025 | $32.9M |
| Q4 2025 | $22M |
| Q4 2025 | $1.2M |
| Q4 2025 | $82 |
| Q4 2025 | $4.7M |
| Q4 2025 | $1.3M |
| Q1 2026 | $65.7M |
| Q1 2026 | $12.6M |
| Q1 2026 | $767K |
| Q1 2026 | $3.3M |
| Q1 2026 | $1.3M |
| Q2 2026 | $57.5M |
| Q2 2026 | $13M |
| Q2 2026 | $586K |
| Q2 2026 | $2.9M |
| Q2 2026 | $1.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.1M | 18.2K | — | — |
| Q2 2026 | $2.9M | 46.2K | — | — |
| Q2 2026 | $586K | 9.3K | — | — |
| Q2 2026 | $13M | 206.2K | — | — |
| Q2 2026 | $57.5M | 913.2K | — | — |
| Q1 2026 | $1.3M | 19.1K | — | — |
| Q1 2026 | $3.3M | 47.7K | — | — |
| Q1 2026 | $767K | 10.9K | — | — |
| Q1 2026 | $12.6M | 179.4K | — | — |
| Q1 2026 | $65.7M | 937.1K | — | — |
| Q4 2025 | $1.3M | 16.0K | — | — |
| Q4 2025 | $4.7M | 57.7K | — | — |
| Q4 2025 | $82 | 1 | — | — |
| Q4 2025 | $1.2M | 14.3K | — | — |
| Q4 2025 | $22M | 268.8K | — | — |
| Q4 2025 | $32.9M | 401.3K | — | — |
| Q3 2025 | $994K | 16.7K | — | — |
| Q3 2025 | $3.9M | 65.3K | — | — |
| Q3 2025 | $59 | 1 | — | — |
| Q3 2025 | $595K | 10.0K | — | — |
| Q3 2025 | $16.2M | 272.1K | — | — |
| Q3 2025 | $10.2M | 171.8K | — | — |
Other funds holding TARS
$155.5M
$126.3M
$105.9M
$101.3M